Kamada (KMDA) EBT Margin (2012 - 2026)

Kamada (KMDA) reported EBT Margin of 11.92% for Q1 2026, down 311.0% on a YoY basis from 5.65% in Q1 2025, and up 12.46% quarter-over-quarter from 10.6% in Q4 2025.

Kamada (KMDA) EBT Margin (2012 - 2026) Analysis & Trends

Kamada has reported EBT Margin for 15 years, with the latest figure at 11.92% in Q1 2026.

  • For the quarter ending Q1 2026, EBT Margin fell 311.0% year-over-year to 11.92%; the trailing twelve-month figure through Mar 2026 stood at 0.04% (up 1.0% YoY), and the FY2025 full-year result was 13.0%, up 472.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 11.92%, up from 10.6% in the prior quarter.
  • The five-year high for EBT Margin was 20.24% in Q3 2025, with the low at 16.58% in Q2 2022.
  • Historically, EBT Margin has averaged 5.36% across 5 years, with a median of 6.46% in 2024.
  • Annual changes were most pronounced in 2022 — EBT Margin sank 2045 bps — and 2023, when it surged 2174 bps.
  • Kamada's EBT Margin stood at 6.48% in 2022, then soared by 113 bps to 13.79% in 2023, then slumped by 54 bps to 6.3% in 2024, then jumped by 68 bps to 10.6% in 2025, then advanced by 12 bps to 11.92% in 2026.
  • The last three EBT Margin figures came in at 11.92% (Q1 2026), 10.6% (Q4 2025), and 20.24% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 10.97%
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 33.51%
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 40.73%
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 25.87%
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 30.30%
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 6.35%
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -156.77%
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 41.45%
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -16.70%
10 Kamada 505.05 -73.15 Mn 19.12 Mn 11.92%

Historic Data

Download Data
DateValue
Mar 31, 2026 11.92%
Dec 31, 2025 10.60%
Sep 30, 2025 20.24%
Jun 30, 2025 0.00%
Mar 31, 2025 15.02%
Dec 31, 2024 6.30%
Sep 30, 2024 9.46%
Jun 30, 2024 0.00%
Mar 31, 2024 6.46%
Dec 31, 2023 13.79%
Sep 30, 2023 8.69%
Jun 30, 2023 5.15%
Mar 31, 2023 0.00%
Dec 31, 2022 6.48%
Sep 30, 2022 0.00%
Jun 30, 2022 -16.58%
Mar 31, 2022 -6.36%
Dec 31, 2021 -14.82%
Sep 30, 2021 -3.67%
Jun 30, 2021 3.87%